These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 9725058
1. [Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy]. Kuribara R, Muroi K, Yoshida M, Suzuki T, Izumi T, Hatake K, Amemiya Y, Miura Y. Gan To Kagaku Ryoho; 1998 Aug; 25(10):1613-7. PubMed ID: 9725058 [No Abstract] [Full Text] [Related]
3. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children]. Rokicka-Milewska R, Derulska D, Lewicki Z. Pediatr Pol; 1988 Nov; 63(11):703-15. PubMed ID: 3253657 [No Abstract] [Full Text] [Related]
4. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method]. Ochocka M, Zelenay E. Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658 [No Abstract] [Full Text] [Related]
5. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia. Chen S, Wu D, Sun A, Qiu H, Jin Z, Tang X, Miao M, Fu Z, Ma X, Han Y, Hu X. Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780 [No Abstract] [Full Text] [Related]
6. [Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children]. Rokicka-Milewska R, Derulska D, Skwarska E. Pol Tyg Lek; 1988 Aug 22; 43(34):1085-7. PubMed ID: 3150782 [No Abstract] [Full Text] [Related]
7. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication. Schrøder H, Kjeldahl M, Boesen AM, Nielsen OJ, Schmidt K, Johnsen HE, Gregersen H, Heyman M, Gustafsson G. Dan Med Bull; 2006 Feb 22; 53(1):76-9. PubMed ID: 16761337 [Abstract] [Full Text] [Related]
8. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia]. Paśnicki M. Wiad Lek; 1995 Feb 22; 48(1-12):194-7. PubMed ID: 9638239 [No Abstract] [Full Text] [Related]
9. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma]. Rubio JA, Pulpón LA, Cavero MA, Oteo JF, Maicas C, Silva L, Serrano-Fiz S, Burgos R, Artaza M, Téllez G. Rev Esp Cardiol; 1994 Nov 22; 47(11):777-9. PubMed ID: 7800910 [Abstract] [Full Text] [Related]
10. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center]. Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J. Cas Lek Cesk; 2002 Mar 01; 141(4):122-6. PubMed ID: 12046256 [Abstract] [Full Text] [Related]
11. Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT). Bredt M, Schönfeld G, Kleeberger W, König E, Kröning H, Kettner E, Al-Ali HK, Niederwieser D, Kreipe H. Bone Marrow Transplant; 2003 Jun 01; 31(11):1071-2. PubMed ID: 12774065 [No Abstract] [Full Text] [Related]
12. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B, German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL). Cancer; 2006 Jan 01; 106(1):136-45. PubMed ID: 16331635 [Abstract] [Full Text] [Related]
13. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]. Schrøder H, Kjeldstad M, Boesen AM, Nielsen OJ, Schmidt KG, Johnsen HE, Gregersen H, Gustafsson G. Ugeskr Laeger; 2006 Jun 26; 168(26-32):2554-8. PubMed ID: 16824410 [Abstract] [Full Text] [Related]
14. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G. Haematologica; 1998 Sep 26; 83(9):791-9. PubMed ID: 9825576 [Abstract] [Full Text] [Related]
15. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product support. Sefcick A, Byrne JL, Russell NH. Bone Marrow Transplant; 2000 Nov 26; 26(10):1140-1. PubMed ID: 11108322 [No Abstract] [Full Text] [Related]
16. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia. Porcellini A, Manna A, Moretti L, Carotenuto M, Greco MM, Bodenizza C. Bone Marrow Transplant; 1989 May 26; 4(3):331-3. PubMed ID: 2659120 [No Abstract] [Full Text] [Related]
17. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia]. Lares-Asseff I, Paredes R, Taboada C, Cravioto J, Velázquez M, Roldán RM, Faisal AG. Bol Med Hosp Infant Mex; 1988 Oct 26; 45(10):671-80. PubMed ID: 3264171 [No Abstract] [Full Text] [Related]